PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET

1396663 Analgesics CHINOIN GYGYSZER ES VEGYESZETI TERMEKEK GYARA RT 2 Aug 1973 [3 Aug 1972 19 Dec 1972] 36873/73 Heading A5B Pharmaceutical compositions having synergistic analgesic activity comprise at least one azido compound of formula (I) or a pharmaceutically acceptable salt thereof such as the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SZLAVIK,LASZLO, NAGY,SANDOR, KNOLL,JOZSEF,DR, FUERST,ZSUZSANNA,DR, HERMECZ,ISTVAN, BOGNAR,REZSO,DR, MESZAROS,ZOLTAN,DR, SZEMMIKLOSI,PETER,DR, VALOVICS,GYULA, DAVID,AGOSTON,DR, MANDI,ATTILA, MAKLEIT,SANDOR,DR
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SZLAVIK,LASZLO
NAGY,SANDOR
KNOLL,JOZSEF,DR
FUERST,ZSUZSANNA,DR
HERMECZ,ISTVAN
BOGNAR,REZSO,DR
MESZAROS,ZOLTAN,DR
SZEMMIKLOSI,PETER,DR
VALOVICS,GYULA
DAVID,AGOSTON,DR
MANDI,ATTILA
MAKLEIT,SANDOR,DR
description 1396663 Analgesics CHINOIN GYGYSZER ES VEGYESZETI TERMEKEK GYARA RT 2 Aug 1973 [3 Aug 1972 19 Dec 1972] 36873/73 Heading A5B Pharmaceutical compositions having synergistic analgesic activity comprise at least one azido compound of formula (I) or a pharmaceutically acceptable salt thereof such as the bitartrate salt wherein R is hydrogen, methyl, ethyl, acetyl or morpholino-methyl in association with at least one compound selected from compounds of formula (II) wherein R1, R2 and R3 are hydrogen or C 1-6 alkyl and the dotted lines represent optionally hydrogenated bonds, and pharmaceutically acceptable salts and quaternary salts thereof such as a chloride, bromide, nitrate, sulphate, methylsulphate or ethylsulphate and analgesic butyrophenone derivatives, optionally in admixture with a pharmaceutically acceptable solid or liquid carrier or diluent. The compound of formula (I) may be azidomorphine, azidocodeine, azidoethylmorphine, azidoacetyl-morphine or azidomorpholinomethyl-morphine, the compound of formula (II) may be 1, 6-dimethyl-3-carbethoxy-4-oxo-6, 7, 8, 9-tetrahydro-homo-pyrimidazolium methosulphate and the butyrophenone derivative is preferably 4'- fluoro-4-[4-[2-oxo-2, 3-dihydrobenzimidazolyl- (1)]-1, 2, 3, 6-tetrahydropyridyl-(1)]-butyrophenone. The compositions may be administered orally or parenterally in the form of tablets, capsules, pills, coated pills, injectable preparations and powder ampoules.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE2338901A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE2338901A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE2338901A13</originalsourceid><addsrcrecordid>eNrjZHAP8HAM8nWMcg0N8Qx29nANVggIcnQNcAxyDFHw9QxRCI70cw1y9wyGyAYpOPo5-ri7wnneIZ5hniGOriE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTexdXI2NjC0sDQ0dCYCCUA3vws0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET</title><source>esp@cenet</source><creator>SZLAVIK,LASZLO ; NAGY,SANDOR ; KNOLL,JOZSEF,DR ; FUERST,ZSUZSANNA,DR ; HERMECZ,ISTVAN ; BOGNAR,REZSO,DR ; MESZAROS,ZOLTAN,DR ; SZEMMIKLOSI,PETER,DR ; VALOVICS,GYULA ; DAVID,AGOSTON,DR ; MANDI,ATTILA ; MAKLEIT,SANDOR,DR</creator><creatorcontrib>SZLAVIK,LASZLO ; NAGY,SANDOR ; KNOLL,JOZSEF,DR ; FUERST,ZSUZSANNA,DR ; HERMECZ,ISTVAN ; BOGNAR,REZSO,DR ; MESZAROS,ZOLTAN,DR ; SZEMMIKLOSI,PETER,DR ; VALOVICS,GYULA ; DAVID,AGOSTON,DR ; MANDI,ATTILA ; MAKLEIT,SANDOR,DR</creatorcontrib><description>1396663 Analgesics CHINOIN GYGYSZER ES VEGYESZETI TERMEKEK GYARA RT 2 Aug 1973 [3 Aug 1972 19 Dec 1972] 36873/73 Heading A5B Pharmaceutical compositions having synergistic analgesic activity comprise at least one azido compound of formula (I) or a pharmaceutically acceptable salt thereof such as the bitartrate salt wherein R is hydrogen, methyl, ethyl, acetyl or morpholino-methyl in association with at least one compound selected from compounds of formula (II) wherein R1, R2 and R3 are hydrogen or C 1-6 alkyl and the dotted lines represent optionally hydrogenated bonds, and pharmaceutically acceptable salts and quaternary salts thereof such as a chloride, bromide, nitrate, sulphate, methylsulphate or ethylsulphate and analgesic butyrophenone derivatives, optionally in admixture with a pharmaceutically acceptable solid or liquid carrier or diluent. The compound of formula (I) may be azidomorphine, azidocodeine, azidoethylmorphine, azidoacetyl-morphine or azidomorpholinomethyl-morphine, the compound of formula (II) may be 1, 6-dimethyl-3-carbethoxy-4-oxo-6, 7, 8, 9-tetrahydro-homo-pyrimidazolium methosulphate and the butyrophenone derivative is preferably 4'- fluoro-4-[4-[2-oxo-2, 3-dihydrobenzimidazolyl- (1)]-1, 2, 3, 6-tetrahydropyridyl-(1)]-butyrophenone. The compositions may be administered orally or parenterally in the form of tablets, capsules, pills, coated pills, injectable preparations and powder ampoules.</description><edition>1</edition><language>ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1974</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19740221&amp;DB=EPODOC&amp;CC=DE&amp;NR=2338901A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19740221&amp;DB=EPODOC&amp;CC=DE&amp;NR=2338901A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SZLAVIK,LASZLO</creatorcontrib><creatorcontrib>NAGY,SANDOR</creatorcontrib><creatorcontrib>KNOLL,JOZSEF,DR</creatorcontrib><creatorcontrib>FUERST,ZSUZSANNA,DR</creatorcontrib><creatorcontrib>HERMECZ,ISTVAN</creatorcontrib><creatorcontrib>BOGNAR,REZSO,DR</creatorcontrib><creatorcontrib>MESZAROS,ZOLTAN,DR</creatorcontrib><creatorcontrib>SZEMMIKLOSI,PETER,DR</creatorcontrib><creatorcontrib>VALOVICS,GYULA</creatorcontrib><creatorcontrib>DAVID,AGOSTON,DR</creatorcontrib><creatorcontrib>MANDI,ATTILA</creatorcontrib><creatorcontrib>MAKLEIT,SANDOR,DR</creatorcontrib><title>PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET</title><description>1396663 Analgesics CHINOIN GYGYSZER ES VEGYESZETI TERMEKEK GYARA RT 2 Aug 1973 [3 Aug 1972 19 Dec 1972] 36873/73 Heading A5B Pharmaceutical compositions having synergistic analgesic activity comprise at least one azido compound of formula (I) or a pharmaceutically acceptable salt thereof such as the bitartrate salt wherein R is hydrogen, methyl, ethyl, acetyl or morpholino-methyl in association with at least one compound selected from compounds of formula (II) wherein R1, R2 and R3 are hydrogen or C 1-6 alkyl and the dotted lines represent optionally hydrogenated bonds, and pharmaceutically acceptable salts and quaternary salts thereof such as a chloride, bromide, nitrate, sulphate, methylsulphate or ethylsulphate and analgesic butyrophenone derivatives, optionally in admixture with a pharmaceutically acceptable solid or liquid carrier or diluent. The compound of formula (I) may be azidomorphine, azidocodeine, azidoethylmorphine, azidoacetyl-morphine or azidomorpholinomethyl-morphine, the compound of formula (II) may be 1, 6-dimethyl-3-carbethoxy-4-oxo-6, 7, 8, 9-tetrahydro-homo-pyrimidazolium methosulphate and the butyrophenone derivative is preferably 4'- fluoro-4-[4-[2-oxo-2, 3-dihydrobenzimidazolyl- (1)]-1, 2, 3, 6-tetrahydropyridyl-(1)]-butyrophenone. The compositions may be administered orally or parenterally in the form of tablets, capsules, pills, coated pills, injectable preparations and powder ampoules.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1974</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAP8HAM8nWMcg0N8Qx29nANVggIcnQNcAxyDFHw9QxRCI70cw1y9wyGyAYpOPo5-ri7wnneIZ5hniGOriE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTexdXI2NjC0sDQ0dCYCCUA3vws0g</recordid><startdate>19740221</startdate><enddate>19740221</enddate><creator>SZLAVIK,LASZLO</creator><creator>NAGY,SANDOR</creator><creator>KNOLL,JOZSEF,DR</creator><creator>FUERST,ZSUZSANNA,DR</creator><creator>HERMECZ,ISTVAN</creator><creator>BOGNAR,REZSO,DR</creator><creator>MESZAROS,ZOLTAN,DR</creator><creator>SZEMMIKLOSI,PETER,DR</creator><creator>VALOVICS,GYULA</creator><creator>DAVID,AGOSTON,DR</creator><creator>MANDI,ATTILA</creator><creator>MAKLEIT,SANDOR,DR</creator><scope>EVB</scope></search><sort><creationdate>19740221</creationdate><title>PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET</title><author>SZLAVIK,LASZLO ; NAGY,SANDOR ; KNOLL,JOZSEF,DR ; FUERST,ZSUZSANNA,DR ; HERMECZ,ISTVAN ; BOGNAR,REZSO,DR ; MESZAROS,ZOLTAN,DR ; SZEMMIKLOSI,PETER,DR ; VALOVICS,GYULA ; DAVID,AGOSTON,DR ; MANDI,ATTILA ; MAKLEIT,SANDOR,DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE2338901A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1974</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SZLAVIK,LASZLO</creatorcontrib><creatorcontrib>NAGY,SANDOR</creatorcontrib><creatorcontrib>KNOLL,JOZSEF,DR</creatorcontrib><creatorcontrib>FUERST,ZSUZSANNA,DR</creatorcontrib><creatorcontrib>HERMECZ,ISTVAN</creatorcontrib><creatorcontrib>BOGNAR,REZSO,DR</creatorcontrib><creatorcontrib>MESZAROS,ZOLTAN,DR</creatorcontrib><creatorcontrib>SZEMMIKLOSI,PETER,DR</creatorcontrib><creatorcontrib>VALOVICS,GYULA</creatorcontrib><creatorcontrib>DAVID,AGOSTON,DR</creatorcontrib><creatorcontrib>MANDI,ATTILA</creatorcontrib><creatorcontrib>MAKLEIT,SANDOR,DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SZLAVIK,LASZLO</au><au>NAGY,SANDOR</au><au>KNOLL,JOZSEF,DR</au><au>FUERST,ZSUZSANNA,DR</au><au>HERMECZ,ISTVAN</au><au>BOGNAR,REZSO,DR</au><au>MESZAROS,ZOLTAN,DR</au><au>SZEMMIKLOSI,PETER,DR</au><au>VALOVICS,GYULA</au><au>DAVID,AGOSTON,DR</au><au>MANDI,ATTILA</au><au>MAKLEIT,SANDOR,DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET</title><date>1974-02-21</date><risdate>1974</risdate><abstract>1396663 Analgesics CHINOIN GYGYSZER ES VEGYESZETI TERMEKEK GYARA RT 2 Aug 1973 [3 Aug 1972 19 Dec 1972] 36873/73 Heading A5B Pharmaceutical compositions having synergistic analgesic activity comprise at least one azido compound of formula (I) or a pharmaceutically acceptable salt thereof such as the bitartrate salt wherein R is hydrogen, methyl, ethyl, acetyl or morpholino-methyl in association with at least one compound selected from compounds of formula (II) wherein R1, R2 and R3 are hydrogen or C 1-6 alkyl and the dotted lines represent optionally hydrogenated bonds, and pharmaceutically acceptable salts and quaternary salts thereof such as a chloride, bromide, nitrate, sulphate, methylsulphate or ethylsulphate and analgesic butyrophenone derivatives, optionally in admixture with a pharmaceutically acceptable solid or liquid carrier or diluent. The compound of formula (I) may be azidomorphine, azidocodeine, azidoethylmorphine, azidoacetyl-morphine or azidomorpholinomethyl-morphine, the compound of formula (II) may be 1, 6-dimethyl-3-carbethoxy-4-oxo-6, 7, 8, 9-tetrahydro-homo-pyrimidazolium methosulphate and the butyrophenone derivative is preferably 4'- fluoro-4-[4-[2-oxo-2, 3-dihydrobenzimidazolyl- (1)]-1, 2, 3, 6-tetrahydropyridyl-(1)]-butyrophenone. The compositions may be administered orally or parenterally in the form of tablets, capsules, pills, coated pills, injectable preparations and powder ampoules.</abstract><edition>1</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_DE2338901A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMAZEUTISCHES PRAEPARAT MIT SYNERGISTISCHER ANALGETISCHER AKTIVITAET
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A18%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SZLAVIK,LASZLO&rft.date=1974-02-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE2338901A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true